25 XP   0   0   10

Phoenix Biotech Acquisition Corp Unit
Buy, Hold or Sell?

Let's analyse Phoenix Biotech Acquisition Corp Unit together

PenkeI guess you are interested in Phoenix Biotech Acquisition Corp Unit. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Phoenix Biotech Acquisition Corp Unit. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Phoenix Biotech Acquisition Corp Unit

I send you an email if I find something interesting about Phoenix Biotech Acquisition Corp Unit.

Quick analysis of Phoenix Biotech Acquisition Corp Unit (30 sec.)










What can you expect buying and holding a share of Phoenix Biotech Acquisition Corp Unit? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$0.54
Expected worth in 1 year
$2.69
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
$2.15
Return On Investment
inf%

For what price can you sell your share?

Current Price per Share
$
Expected price per share
$0 - $
How sure are you?
50%

1. Valuation of Phoenix Biotech Acquisition Corp Unit (5 min.)




Live pricePrice per Share (EOD)

$

2. Growth of Phoenix Biotech Acquisition Corp Unit (5 min.)




Is Phoenix Biotech Acquisition Corp Unit growing?

Current yearPrevious yearGrowGrow %
How rich?$2.4m???

How much money is Phoenix Biotech Acquisition Corp Unit making?

Current yearPrevious yearGrowGrow %
Making money-$667.7k???
Net Profit Margin-262.0%?--

How much money comes from the company's main activities?

3. Financial Health of Phoenix Biotech Acquisition Corp Unit (5 min.)




4. Comparing to competitors in the Shell Companies industry (5 min.)




  Industry Rankings (Shell Companies)  


Richest
#209 / 220

Most Revenue
#40 / 220

Most Profit
#192 / 220

Most Efficient
#195 / 220

What can you expect buying and holding a share of Phoenix Biotech Acquisition Corp Unit? (5 min.)

Welcome investor! Phoenix Biotech Acquisition Corp Unit's management wants to use your money to grow the business. In return you get a share of Phoenix Biotech Acquisition Corp Unit.

What can you expect buying and holding a share of Phoenix Biotech Acquisition Corp Unit?

First you should know what it really means to hold a share of Phoenix Biotech Acquisition Corp Unit. And how you can make/lose money.

Speculation

The Price per Share of Phoenix Biotech Acquisition Corp Unit is $. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Phoenix Biotech Acquisition Corp Unit.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Phoenix Biotech Acquisition Corp Unit, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.54. Based on the TTM, the Book Value Change Per Share is $0.54 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Phoenix Biotech Acquisition Corp Unit.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.15-0.15-0.15-0.15
Usd Book Value Change Per Share0.540.540.540.54
Usd Dividend Per Share0.000.000.000.00
Usd Total Gains Per Share0.540.540.540.54
Usd Price Per Share0.00-0.00-0.00-0.00-
Price to Earnings Ratio0.00-0.00-0.00-0.00-
Price-to-Total Gains Ratio
Price to Book Ratio0.00-0.00-0.00-0.00-
Price-to-Total Gains Ratio

When do you get the money?

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.01.00.00.0%0.01.00.00.0%0.01.00.00.0%0.01.00.00.0%
Book Value Change Per Share1.00.00.0100.0%1.00.00.0100.0%1.00.00.0100.0%1.00.00.0100.0%1.00.00.0100.0%
Dividend per Share0.00.01.00.0%0.00.01.00.0%0.00.01.00.0%0.00.01.00.0%0.00.01.00.0%
Total Gains per Share1.00.00.0100.0%1.00.00.0100.0%1.00.00.0100.0%1.00.00.0100.0%1.00.00.0100.0%

Fundamentals of Phoenix Biotech Acquisition Corp Unit

About Phoenix Biotech Acquisition Corp Unit

Phoenix Biotech Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It engages in identifying and acquiring a business that focuses on the healthcare or healthcare related industries in the United States and Europe. Phoenix Biotech Acquisition Corp. was incorporated in 2021 and is based in Oakland, California.

Fundamental data was last updated by Penke on 2023-08-28 21:57:02.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry

1.1. Profitability of Phoenix Biotech Acquisition Corp Unit.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Phoenix Biotech Acquisition Corp Unit earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Phoenix Biotech Acquisition Corp Unit to the Shell Companies industry mean.
  • A Net Profit Margin of -262.0% means that $-2.62 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Phoenix Biotech Acquisition Corp Unit:

  • The MRQ is -262.0%. The company is making a huge loss. -2
  • The TTM is -262.0%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-262.0%TTM-262.0%0.0%
TTM-262.0%5Y-262.0%0.0%
5Y-262.0%10Y-262.0%0.0%
Compared to industry (Shell Companies)
PeriodCompanyIndustry (mean)+/- 
MRQ-262.0%-86.2%-175.8%
TTM-262.0%-13.2%-248.8%
5Y-262.0%-26.8%-235.2%
10Y-262.0%-29.1%-232.9%
1.1.2. Return on Assets

Shows how efficient Phoenix Biotech Acquisition Corp Unit is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Phoenix Biotech Acquisition Corp Unit to the Shell Companies industry mean.
  • -1.6% Return on Assets means that Phoenix Biotech Acquisition Corp Unit generated $-0.02 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Phoenix Biotech Acquisition Corp Unit:

  • The MRQ is -1.6%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -1.6%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-1.6%TTM-1.6%0.0%
TTM-1.6%5Y-1.6%0.0%
5Y-1.6%10Y-1.6%0.0%
Compared to industry (Shell Companies)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.6%0.1%-1.7%
TTM-1.6%0.3%-1.9%
5Y-1.6%-0.5%-1.1%
10Y-1.6%-0.5%-1.1%
1.1.3. Return on Equity

Shows how efficient Phoenix Biotech Acquisition Corp Unit is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Phoenix Biotech Acquisition Corp Unit to the Shell Companies industry mean.
  • -27.0% Return on Equity means Phoenix Biotech Acquisition Corp Unit generated $-0.27 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Phoenix Biotech Acquisition Corp Unit:

  • The MRQ is -27.0%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -27.0%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-27.0%TTM-27.0%0.0%
TTM-27.0%5Y-27.0%0.0%
5Y-27.0%10Y-27.0%0.0%
Compared to industry (Shell Companies)
PeriodCompanyIndustry (mean)+/- 
MRQ-27.0%0.7%-27.7%
TTM-27.0%0.6%-27.6%
5Y-27.0%-0.8%-26.2%
10Y-27.0%-0.7%-26.3%

1.2. Operating Efficiency of Phoenix Biotech Acquisition Corp Unit.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Phoenix Biotech Acquisition Corp Unit is operating .

  • Measures how much profit Phoenix Biotech Acquisition Corp Unit makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Phoenix Biotech Acquisition Corp Unit to the Shell Companies industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Phoenix Biotech Acquisition Corp Unit:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Shell Companies)
PeriodCompanyIndustry (mean)+/- 
MRQ--103.5%+103.5%
TTM--23.0%+23.0%
5Y--33.1%+33.1%
10Y--44.8%+44.8%
1.2.2. Operating Ratio

Measures how efficient Phoenix Biotech Acquisition Corp Unit is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Shell Companies industry mean).
  • An Operation Ratio of 11.40 means that the operating costs are $11.40 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Phoenix Biotech Acquisition Corp Unit:

  • The MRQ is 11.401. The company is inefficient in keeping operating costs low. -1
  • The TTM is 11.401. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ11.401TTM11.4010.000
TTM11.4015Y11.4010.000
5Y11.40110Y11.4010.000
Compared to industry (Shell Companies)
PeriodCompanyIndustry (mean)+/- 
MRQ11.4011.873+9.528
TTM11.4011.116+10.285
5Y11.4010.666+10.735
10Y11.4010.926+10.475

1.3. Liquidity of Phoenix Biotech Acquisition Corp Unit.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Phoenix Biotech Acquisition Corp Unit is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Shell Companies industry mean).
  • A Current Ratio of 1.38 means the company has $1.38 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Phoenix Biotech Acquisition Corp Unit:

  • The MRQ is 1.378. The company is just able to pay all its short-term debts.
  • The TTM is 1.378. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.378TTM1.3780.000
TTM1.3785Y1.3780.000
5Y1.37810Y1.3780.000
Compared to industry (Shell Companies)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3780.062+1.316
TTM1.3780.255+1.123
5Y1.3781.963-0.585
10Y1.3781.832-0.454
1.3.2. Quick Ratio

Measures if Phoenix Biotech Acquisition Corp Unit is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Phoenix Biotech Acquisition Corp Unit to the Shell Companies industry mean.
  • A Quick Ratio of 0.02 means the company can pay off $0.02 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Phoenix Biotech Acquisition Corp Unit:

  • The MRQ is 0.015. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.015. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.015TTM0.0150.000
TTM0.0155Y0.0150.000
5Y0.01510Y0.0150.000
Compared to industry (Shell Companies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0150.179-0.164
TTM0.0150.715-0.700
5Y0.0153.956-3.941
10Y0.0154.007-3.992

1.4. Solvency of Phoenix Biotech Acquisition Corp Unit.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Phoenix Biotech Acquisition Corp Unit assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Phoenix Biotech Acquisition Corp Unit to Shell Companies industry mean.
  • A Debt to Asset Ratio of 0.94 means that Phoenix Biotech Acquisition Corp Unit assets are financed with 94.2% credit (debt) and the remaining percentage (100% - 94.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Phoenix Biotech Acquisition Corp Unit:

  • The MRQ is 0.942. The company is just able to pay all its debts by selling its assets.
  • The TTM is 0.942. The company is just able to pay all its debts by selling its assets.
Trends
Current periodCompared to+/- 
MRQ0.942TTM0.9420.000
TTM0.9425Y0.9420.000
5Y0.94210Y0.9420.000
Compared to industry (Shell Companies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9420.283+0.659
TTM0.9420.199+0.743
5Y0.9420.310+0.632
10Y0.9420.314+0.628
1.4.2. Debt to Equity Ratio

Measures if Phoenix Biotech Acquisition Corp Unit is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Phoenix Biotech Acquisition Corp Unit to the Shell Companies industry mean.
  • A Debt to Equity ratio of 1,616.2% means that company has $16.16 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Phoenix Biotech Acquisition Corp Unit:

  • The MRQ is 16.162. The company is unable to pay all its debts with equity. -1
  • The TTM is 16.162. The company is unable to pay all its debts with equity. -1
Trends
Current periodCompared to+/- 
MRQ16.162TTM16.1620.000
TTM16.1625Y16.1620.000
5Y16.16210Y16.1620.000
Compared to industry (Shell Companies)
PeriodCompanyIndustry (mean)+/- 
MRQ16.1620.242+15.920
TTM16.1620.201+15.961
5Y16.1620.965+15.197
10Y16.1620.976+15.186

2. Market Valuation of Phoenix Biotech Acquisition Corp Unit

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Phoenix Biotech Acquisition Corp Unit generates.

  • Above 15 is considered overpriced but always compare Phoenix Biotech Acquisition Corp Unit to the Shell Companies industry mean.
  • A PE ratio of 0.00 means the investor is paying $0.00 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Phoenix Biotech Acquisition Corp Unit:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
EOD-MRQ-0.000
MRQ-TTM-0.000
TTM-5Y-0.000
5Y-10Y-0.000
Compared to industry (Shell Companies)
PeriodCompanyIndustry (mean)+/- 
EOD--0.027+0.027
MRQ--0.870+0.870
TTM-5.382-5.382
5Y--4.479+4.479
10Y--4.416+4.416
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Phoenix Biotech Acquisition Corp Unit:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
EOD-MRQ-0.000
MRQ-TTM-0.000
TTM-5Y-0.000
5Y-10Y-0.000
Compared to industry (Shell Companies)
PeriodCompanyIndustry (mean)+/- 
EOD--75.422+75.422
MRQ--77.828+77.828
TTM--150.309+150.309
5Y--212.676+212.676
10Y--211.728+211.728
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Phoenix Biotech Acquisition Corp Unit is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Shell Companies industry mean).
  • A PB ratio of 0.00 means the investor is paying $0.00 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Phoenix Biotech Acquisition Corp Unit:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
EOD-MRQ-0.000
MRQ-TTM-0.000
TTM-5Y-0.000
5Y-10Y-0.000
Compared to industry (Shell Companies)
PeriodCompanyIndustry (mean)+/- 
EOD-2.286-2.286
MRQ-2.292-2.292
TTM-2.067-2.067
5Y-1.458-1.458
10Y-1.497-1.497
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Phoenix Biotech Acquisition Corp Unit.

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Phoenix Biotech Acquisition Corp Unit compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.5370.5370%--0.5370%0.5370%
Book Value Per Share--0.5370.5370%--0.5370%0.5370%
Current Ratio--1.3781.3780%--1.3780%1.3780%
Debt To Asset Ratio--0.9420.9420%--0.9420%0.9420%
Debt To Equity Ratio--16.16216.1620%--16.1620%16.1620%
Dividend Per Share----0%---0%-0%
Eps---0.145-0.1450%---0.1450%-0.1450%
Free Cash Flow Per Share---0.238-0.2380%---0.2380%-0.2380%
Free Cash Flow To Equity Per Share---30.415-30.4150%---30.4150%-30.4150%
Gross Profit Margin--1.0001.0000%--1.0000%1.0000%
Market Cap----0%---0%-0%
Net Profit Margin---2.620-2.6200%---2.6200%-2.6200%
Operating Margin----0%---0%-0%
Operating Ratio--11.40111.4010%--11.4010%11.4010%
Pb Ratio-0%--0%---0%-0%
Pe Ratio-0%--0%---0%-0%
Price Per Share-0%--0%---0%-0%
Price To Free Cash Flow Ratio-0%--0%---0%-0%
Quick Ratio--0.0150.0150%--0.0150%0.0150%
Return On Assets---0.016-0.0160%---0.0160%-0.0160%
Return On Equity---0.270-0.2700%---0.2700%-0.2700%
Total Gains Per Share--0.5370.5370%--0.5370%0.5370%
Usd Book Value--2468691.0002468691.0000%--2468691.0000%2468691.0000%
Usd Book Value Change Per Share--0.5370.5370%--0.5370%0.5370%
Usd Book Value Per Share--0.5370.5370%--0.5370%0.5370%
Usd Dividend Per Share----0%---0%-0%
Usd Eps---0.145-0.1450%---0.1450%-0.1450%
Usd Free Cash Flow---1092247.000-1092247.0000%---1092247.0000%-1092247.0000%
Usd Free Cash Flow Per Share---0.238-0.2380%---0.2380%-0.2380%
Usd Free Cash Flow To Equity Per Share---30.415-30.4150%---30.4150%-30.4150%
Usd Market Cap----0%---0%-0%
Usd Price Per Share-0%--0%---0%-0%
Usd Profit---667736.000-667736.0000%---667736.0000%-667736.0000%
Usd Revenue--254831.000254831.0000%--254831.0000%254831.0000%
Usd Total Gains Per Share--0.5370.5370%--0.5370%0.5370%
 EOD+0 -0MRQTTM+0 -0YOY+0 -05Y+0 -010Y+0 -0

4.2. Fundamental Score

Let's check the fundamental score of Phoenix Biotech Acquisition Corp Unit based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-150.000
Price to Book Ratio (EOD)Between0-10.000
Net Profit Margin (MRQ)Greater than0-2.620
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.015
Current Ratio (MRQ)Greater than11.378
Debt to Asset Ratio (MRQ)Less than10.942
Debt to Equity Ratio (MRQ)Less than116.162
Return on Equity (MRQ)Greater than0.15-0.270
Return on Assets (MRQ)Greater than0.05-0.016
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Phoenix Biotech Acquisition Corp Unit based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
Total0/0 (0.0%)



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets42,367
Total Liabilities39,898
Total Stockholder Equity2,469
 As reported
Total Liabilities 39,898
Total Stockholder Equity+ 2,469
Total Assets = 42,367

Assets

Total Assets42,367
Total Current Assets42,367
Long-term Assets0
Total Current Assets
Cash And Cash Equivalents 476
Other Current Assets 225
Total Current Assets  (as reported)42,367
Total Current Assets  (calculated)701
+/- 41,666
Long-term Assets
Long-term Assets  (as reported)0
Long-term Assets  (calculated)0
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities30,748
Long-term Liabilities9,150
Total Stockholder Equity2,469
Total Current Liabilities
Short-term Debt 650
Short Long Term Debt 650
Accounts payable 1,653
Other Current Liabilities 28,445
Total Current Liabilities  (as reported)30,748
Total Current Liabilities  (calculated)31,398
+/- 650
Long-term Liabilities
Long-term Liabilities  (as reported)9,150
Long-term Liabilities  (calculated)0
+/- 9,150
Total Stockholder Equity
Common Stock13,225
Retained Earnings -10,756
Total Stockholder Equity (as reported)2,469
Total Stockholder Equity (calculated)2,469
+/-0
Other
Capital Stock13,225
Cash and Short Term Investments 476
Common Stock Shares Outstanding 4,596
Liabilities and Stockholders Equity 42,367
Net Debt 174
Net Invested Capital 3,119
Net Working Capital 11,619
Short Long Term Debt Total 650



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2022-12-312021-12-31
> Total Assets 
180,078
42,367
42,367180,078
   > Total Current Assets 
1,361
42,367
42,3671,361
       Cash And Cash Equivalents 
1,099
476
4761,099
       Other Current Assets 
263
225
225263
   > Long-term Assets 
178,717
0
0178,717
       Long-term Assets Other 
178,647
0
0178,647
> Total Liabilities 
9,248
39,898
39,8989,248
   > Total Current Liabilities 
98
30,748
30,74898
       Short-term Debt 
0
650
6500
       Short Long Term Debt 
0
650
6500
       Accounts payable 
14
1,653
1,65314
       Other Current Liabilities 
84
28,445
28,44584
   > Long-term Liabilities 
9,150
9,150
9,1509,150
> Total Stockholder Equity
170,830
2,469
2,469170,830
   Common Stock
178,501
13,225
13,225178,501
   Retained Earnings -10,756-7,670
   Accumulated Other Comprehensive Income 00
   Capital Surplus 00
   Treasury Stock00



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2022-12-31)

Gross Profit (+$)
totalRevenue255
Cost of Revenue-0
Gross Profit255255
 
Operating Income (+$)
Gross Profit255
Operating Expense-2,905
Operating Income-5,742-2,651
 
Operating Expense (+$)
Research Development0
Selling General Administrative2,841
Selling And Marketing Expenses0
Operating Expense2,9052,841
 
Net Interest Income (+$)
Interest Income0
Interest Expense-5,674
Other Finance Cost-5,674
Net Interest Income0
 
Pretax Income (+$)
Operating Income-5,742
Net Interest Income0
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-69-11,416
EBIT - interestExpense = -5,674
-69
5,006
Interest Expense5,674
Earnings Before Interest and Taxes (EBIT)05,605
Earnings Before Interest and Taxes (EBITDA)-5,742
 
After tax Income (+$)
Income Before Tax-69
Tax Provision-599
Net Income From Continuing Ops-668-668
Net Income-668
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses2,905
Total Other Income/Expenses Net5,6740
 

1.4. Technical Score

Let's check the technical score of Phoenix Biotech Acquisition Corp Unit based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
Total0/0 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Phoenix Biotech Acquisition Corp Unit with someone you think should read this too:
  • Are you bullish or bearish on Phoenix Biotech Acquisition Corp Unit? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Phoenix Biotech Acquisition Corp Unit? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Phoenix Biotech Acquisition Corp Unit

I send you an email if I find something interesting about Phoenix Biotech Acquisition Corp Unit.


Comments

How you think about this?

Leave a comment

Stay informed about Phoenix Biotech Acquisition Corp Unit.

Receive notifications about Phoenix Biotech Acquisition Corp Unit in your mailbox!